Sweden Sepsis Diagnostics Market Size & Outlook, 2022-2030
Sweden sepsis diagnostics market, 2018-2030 (US$M)
Related Markets
Sweden sepsis diagnostics market highlights
- The Sweden sepsis diagnostics market generated a revenue of USD 3.1 million in 2022 and is expected to reach USD 4.9 million by 2030.
- The Sweden market is expected to grow at a CAGR of 6.2% from 2023 to 2030.
- In terms of segment, blood culture media was the largest revenue generating product in 2022.
- Assay Kits & Reagents is the most lucrative product segment registering the fastest growth during the forecast period.
Sepsis diagnostics market data book summary
| Market revenue in 2022 | USD 3.1 million |
| Market revenue in 2030 | USD 4.9 million |
| Growth rate | 6.2% (CAGR from 2022 to 2030) |
| Largest segment | Blood culture media |
| Fastest growing segment | Assay Kits & Reagents |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Blood Culture Media, Assay Kits & Reagents, Software |
| Key market players worldwide | BD, BioMerieux SA, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG ADR, Luminex, Koninklijke Philips NV, Bruker Corp, Cepheid, Immunexpress |
Other key industry trends
- In terms of revenue, Sweden accounted for 0.3% of the global sepsis diagnostics market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany sepsis diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 82.5 million by 2030.
Blood culture media was the largest segment with a revenue share of 38.71% in 2022. Horizon Databook has segmented the Sweden sepsis diagnostics market based on instruments, blood culture media, assay kits & reagents, software covering the revenue growth of each sub-segment from 2018 to 2030.
The growing prevalence of sepsis in Sweden highlights the importance of effective diagnostic tools for early detection and management. In August 2023, a research team at Lund University in Sweden has identified that sepsis is associated with more than 4% of all hospital admissions in Southern Sweden.
This notable statistic highlights the widespread impact of sepsis in the regional healthcare system, revealing a pressing need for enhanced diagnostic and therapeutic approaches. Sweden has the most innovative healthcare system, which is contributing to several advancements in medical technology, including sepsis diagnostics.
In February 2023, a research study was published in Market Screener, which stated that Gentian Diagnostics ASA in partnership with Karolinska University Hospital studied the potential use of calprotectin in treating patients with suspected sepsis.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Sepsis Diagnostics Market Scope
Sepsis Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Sweden sepsis diagnostics market size, by product, 2018-2030 (US$M)
Sweden Sepsis Diagnostics Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
